Stay updated with breaking news from Lisa Conte. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The drug candidate demonstrates antipsychotic activity and has a mechanism of action distinct from FDA-approved therapies for schizophrenia and other mental conditions that present psychotic symptomsJaguar
Reverse split approved at April 2024 Special Meeting of Stockholders
Jaguar Health shares are falling Monday after the company announced a 1-for-60 reverse stock split. The company will effect a reverse stock split at an exchange ratio of 1-for-60, on Thursday, in order to support the company's compliance with Nasdaq's listing standards.
Jaguar's novel plant-based prescription drug crofelemer has been granted Orphan Drug Designation by the FDA and the European Medicines Agency for both MVID and short bowel syndrome (SBS) with intestinal failureProof-of-concept studies of crofelemer for MVID and SBS planned for 2024 SAN FRANCISCO, CA / ACCESSWIRE / A...
Jaguar planning to begin commercial launch of FDA-approved Gelclair® prescription gel for oral mucositis (also called “chemo mouth”) in Q3 2024